Litcius/Paper detail

Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics

Paul J. Carter, Valerie Quarmby

2024Nature Reviews Drug Discovery76 citationsDOI

Topics & Concepts

ImmunogenicityAntibodyMedicineImmunologyVirologyComputational biologyBiologyBiosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy research
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics | Litcius